The global bioinformatics market was valued at USD 10.1 billion in 2022 and is projected to experience substantial growth, with an anticipated compound annual growth rate (CAGR) of 13.7% from 2023 to 2030. This growth is primarily driven by increasing demand for novel drug research and development (R&D) and the support of both private and public funding initiatives aimed at advancing R&D activities. Additionally, the emergence of user-friendly and accessible bioinformatics software, such as RasMol, AUTODOCK, BALL, and Bioclipse, is contributing to the market's expansion. These tools are widely utilized for the precise and effective analysis of biomarker discovery programs, which are essential for toxicity detection in the early stages of drug development.

Bioinformatics software and tools serve as integrated solutions that provide sophisticated algorithms and statistical methodologies for data analysis. They facilitate the integration of data management and analysis for a variety of applications, including next-generation sequencing, genomic and proteomic structuring, modeling, and three-dimensional drug design. The rising number of R&D initiatives in the proteomics and genomics sectors, along with other related '-omics' fields, is expected to bolster market growth by addressing increasing demands for data storage and analysis.

According to a study published by Stanford Medicine in January 2022, research conducted by Stanford scientists demonstrated that a DNA sequencing technique could sequence a human genome in approximately eight hours. Such technological advancements are likely to enhance the demand for genomics and, consequently, the bioinformatics sector. Applications in bioinformatics are capable of storing vast amounts of genomic and proteomic data, which supports research activities across various fields, including aging, carcinogenesis, and preventive therapies for genetic diseases. This capability is projected to significantly contribute to the industry's growth throughout the forecast period.

Gather more insights about the market drivers, restrains and growth of the Bioinformatics Market

Application Insights

In 2022, the genomics application segment accounted for a considerable share of the revenue in the bioinformatics market. The rising demand for pharmacogenomics in drug development, alongside advancements in technology aimed at managing extensive genomic data sets, are key factors driving this significant market share. The market is categorized into several application segments, including genomics, molecular phylogenetics, metabolomics, proteomics, transcriptomics, cheminformatics, drug designing, and others.

The cheminformatics segment is anticipated to expand notably during the forecast period, primarily driven by the increasing demand for biomarker discovery and development. Cost reductions in the drug development process, shortened timelines for introducing new drugs to market, and enhanced success rates in drug discovery attributed to cheminformatics and drug design are expected to further fuel the growth of this segment.

By integrating bioinformatics with cheminformatics and drug design, researchers can quickly analyze and interpret large volumes of chemical and biological data. This integration leads to more targeted and effective drug development efforts. For example, in June 2021, the U.S. Food and Drug Administration (FDA) and the Center for Drug Evaluation and Research (CDER) approved 26 new molecular entities (NMEs), which will further stimulate growth in research and development activities.

The field of proteomics has also seen significant R&D investments in recent years, and bioinformatics plays a crucial role in analyzing and managing the resulting data. This integration simplifies the handling of heterogeneous and large datasets, allows for the introduction of innovative algorithms, and enhances the knowledge discovery process. Overall, the bioinformatics market is poised for substantial growth, driven by technological advancements, increased funding, and an expanding array of applications across various scientific fields.

Order a free sample PDF of the Bioinformatics Market Intelligence Study, published by Grand View Research.